Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer

por Mamdani, Hirva, Jalal, Shadia I
Publicado 2017

Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?

por Mamdani, Hirva, Jalal, Shadia I.
Publicado 2020

Immunotherapy in Lung Cancer: Current Landscape and Future Directions

por Mamdani, Hirva, Matosevic, Sandro, Khalid, Ahmed Bilal, Durm, Gregory, Jalal, Shadia I.
Publicado 2022

Gastroesophageal junction adenocarcinoma displays abnormalities in homologous recombination and nucleotide excision repair

por Dewalt, Robin I, Kesler, Kenneth A, Hammoud, Zane T, Baldridge, LeeAnn, Hattab, Eyas M, Jalal, Shadia I
Publicado 2014

Tissue dynamics spectroscopic imaging: functional imaging of heterogeneous cancer tissue

por Li, Zhe, Hu, Bihe, Li, Guang, Fox, Sharon E., Jalal, Shadia I., Turek, John, Brown, J. Quincy, Nolte, David D.
Publicado 2020

A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors

por Sharman, Jeffrey P., Wheler, Jennifer J., Einhorn, Lawrence, Dowlati, Afshin, Shapiro, Geoffrey I., Hilton, John, Burke, John M., Siddiqi, Tanya, Whiting, Nancy, Jalal, Shadia I.
Publicado 2019

In Vivo Targeting Replication Protein A for Cancer Therapy

por VanderVere-Carozza, Pamela S., Gavande, Navnath S., Jalal, Shadia I., Pollok, Karen E., Ekinci, Elmira, Heyza, Joshua, Patrick, Steve M., Masters, Andi, Turchi, John J., Pawelczak, Katherine S.
Publicado 2022

A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consor...

por Mamdani, Hirva, Schneider, Bryan, Perkins, Susan M., Burney, Heather N., Kasi, Pashtoon Murtaza, Abushahin, Laith I., Birdas, Thomas, Kesler, Kenneth, Watkins, Tracy M., Badve, Sunil S., Radovich, Milan, Jalal, Shadia I.
Publicado 2021

Impact of smoke-free ordinance strength on smoking prevalence and lung cancer incidence

por Nguyen, Ryan H., Vater, Laura B., Timsina, Lava R., Durm, Gregory A., Rupp, Katelin, Wright, Keylee, Spitznagle, Miranda H., Paul, Brandy, Jalal, Shadia I., Carter-Harris, Lisa, Hudmon, Karen S., Hanna, Nasser H., Loehrer, Patrick J., Ceppa, DuyKhanh P.
Publicado 2021

Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase...

por Bang, Yung-Jue, Kang, Yoon-Koo, Catenacci, Daniel V., Muro, Kei, Fuchs, Charles S., Geva, Ravit, Hara, Hiroki, Golan, Talia, Garrido, Marcelo, Jalal, Shadia I., Borg, Christophe, Doi, Toshihiko, Yoon, Harry H., Savage, Mary J., Wang, Jiangdian, Dalal, Rita P., Shah, Sukrut, Wainberg, Zev A., Chung, Hyun Cheol
Publicado 2019

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma

por Jamieson, Stephen M.F., Tsai, Peter, Kondratyev, Maria K., Budhani, Pratha, Liu, Arthur, Senzer, Neil N., Chiorean, E. Gabriela, Jalal, Shadia I., Nemunaitis, John J., Kee, Dennis, Shome, Avik, Wong, Way W., Li, Dan, Poonawala-Lohani, Nooriyah, Kakadia, Purvi M., Knowlton, Nicholas S., Lynch, Courtney R.H., Hong, Cho R., Lee, Tet Woo, Grénman, Reidar A., Caporiccio, Laura, McKee, Trevor D., Zaidi, Mark, Butt, Sehrish, Macann, Andrew M.J., McIvor, Nicholas P., Chaplin, John M., Hicks, Kevin O., Bohlander, Stefan K., Wouters, Bradly G., Hart, Charles P., Print, Cristin G., Wilson, William R., Curran, Michael A., Hunter, Francis W.
Publicado 2023